Transcription of PTSD: From neurobiology to treatment
{{id}} {{{paragraph}}}
ptsd : from neurobiology to treatment John H. Krystal, VA National Center for ptsd Yale University Disclosures Sources of Research Support of Veterans Affairs, VA National Center for ptsd of Veterans Affairs/Department of Defense, Consortium for the Alleviation of ptsd Center for Advancing Translational Science, NIH Institute on Alcohol Abuse and Alcoholism Institute of Mental Health Paid Editorial Relationship Biological Psychiatry - Editor Consulting Relationship (>$5,000/yr) Janssen Stock Equity (>$10,000) BioHaven Medical Sciences Patents: 1. Glutamatergic treatments for anxiety disorders (Biohaven Medical Sciences) ketamine for depression (Johnson & Johnson) receptor modulation for alcoholism (pending) Speaker s Bureau: None Clinical Neuroscience Division VA National Center for ptsd Steven Southwick Chadi Abdallah Joel Gelernter Robb Pietrzak Ronald Duman Arie Kaffman Ilan Harpaz-Rotem Ifat Levy Irena Esterlis Kel
Disclosures Sources of Research Support 1. Department of Veterans Affairs, VA National Center for PTSD 2. Department of Veterans Affairs/Department of Defense,
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
For Training on the Neurobiology of, Neurobiology, Neurobiology of Opioid Dependence: Implications, Neurobiology of Opioid Dependence: Implications for Treatment, The Neurobiology of Addiction, And 12 – Autonomic nervous system, Bipolar disorder, Neurobiology of PTSD, Neurobiology of Happiness, Neurobiology of Addiction presentation